Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.

Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J. Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg. 2015;120(6):1273-85. DOI: 10.1213/ANE.0000000000000672. PubMed PMID: 25988636.

Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. JAMA. 2016;315(10):1034-45. DOI: 10.1001/jama.2016.0299. PubMed PMID: 26954412.

Anticholinergic effects of medication in elderly patients.

Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62 Suppl 21:11-4. PubMed PMID: 11584981.

Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.

Cao Y-J, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83(3):422-9. DOI: 10.1038/sj.clpt.6100303. PubMed PMID: 17713474.

Health outcomes associated with potentially inappropriate medication use in older adults.

Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Res. Nurs. Health. 2008;31(1):42-51. DOI: 10.1002/nur.20232. PubMed PMID: 18163447; PubMed Central PMCID: PMC2247370.

Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.

Stone-Brown K, Naji M, Francioni A, Myers K, Samarendra H, Mushtaq-Chaudhry H, et al. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital. CNS Spectr. 2016;21(1):60-9. DOI: 10.1017/S1092852915000784. PubMed PMID: 26726766.

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, et al.. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacol. 2015;25(6):763-72. DOI: 10.1016/j.euroneuro.2015.03.017. PubMed PMID: 25907249.

A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.

Pascual JC, Martín-Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, et al.. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. Int Clin Psychopharmacol. 2010;25(6):349-55. DOI: 10.1097/YIC.0b013e32833e23ed. PubMed PMID: 20838221.

Treatment histories of borderline inpatients.

Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry. 2001;42(2):144-50. DOI: 10.1053/comp.2001.19749. PubMed PMID: 11244151.

Medication for borderline personality disorder: a survey at a secure hospital.

Haw C, Stubbs J. Medication for borderline personality disorder: a survey at a secure hospital. Int J Psychiatry Clin Pract. 2011;15(4):280-5. DOI: 10.3109/13651501.2011.590211. PubMed PMID: 22122000.